Webcast CME

Series Activities

Series Menu


Visit Virtual Exhibit Hall

Medical Dermatology Therapy Update



Rheum/Derm Overlap Diseases – Updates and Optimization of Medical Therapy

Print this Content

Release Date:   December 16, 2020
Expiration Date:   December 16, 2022

Estimated Time of Completion:  1 hour and 45 minutes

Description

Medical Dermatology Therapy Update online series will provide a review of traditional therapeutics, as well as biologic and small-molecule therapies, as it applies to a range of important medical dermatologic conditions. In addition it includes an overview of the pathogenesis and diagnosis of various medical dermatologic diseases.

The Rheum/Derm Overlap Diseases – Updates and Optimization of Medical Therapy webcast will review the following medical conditions: dermatomyositis, cutaneous lupus, fibrosing skin disease, and cutaneous vasculitis.

Learning Objectives

  1. Describe how to diagnose and the different clinical manifestations of systemic sclerosis.
  2. Describe the current state of the art treatment and investigational medications for localized scleroderma and systemic sclerosis.
  3. List treatable complications and urgencies.
  4. Review the latest understanding of pathogenesis.
  5. Effectively diagnose dermatomyositis.
  6. Construct a plan for the evaluation of a patient diagnosed with dermatomyositis.
  7. Manage patients with cutaneous dermatomyositis.
  8. Review current standard of care therapeutics for the treatment of cutaneous lupus erythematosus (LE).
  9. Review second line treatments for cutaneous LE.
  10. Become familiar with potential upcoming treatments and their supportive data.

Target Audience

These activities are directed to physicians and advanced practice clinicians in dermatology, immunology, oncology, rheumatology, internal medicine, and other health care professionals caring for patients with autoimmune, chronic inflammatory, and advanced malignant diseases.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.75 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Activity Director and Faculty

Activity Director

Anthony P. Fernandez, MD, PhD
Director of Medical Dermatology
Department of Dermatology
Dermatology and Plastic Surgery Institute
Cleveland Clinic
Cleveland, OH

Faculty

Jeffrey Callen, MD
University of Louisville School of Medicine
Louisville, KY

Robert Lafyatis, MD
Professor of Medicine and the Thomas Medsger Professor in Arthritis Research
University of Pittsburgh School of Medicine
Pittsburgh, PA

Emily Littlejohn, DO, MPH
Department of Rheumatic and Immunologic Disease
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Robert Micheletti, MD
Assistant Professor of Dermatology and Medicine
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty has indicated that he may have a relationship which, in the context of his presentation, could be perceived as a potential conflict of interest:


Anthony P. Fernandez, MD, PhD
  AbbVie Pharmaceuticals Consulting
Membership on advisory committee or review panels
Teaching and Speaking
  Celgene Corporation Consulting
  Corbus Pharmaceuticals Research / Independent Contractor
  Mallinckrodt Inc. Consulting
Research / Independent Contractor
Teaching and Speaking
  Novartis Consulting
Research / Independent Contractor
Teaching and Speaking
  Pfizer, Inc. Research / Independent Contractor
  Roche Pharmaceuticals Principal Investigator for a Phase III Clinical Trial
  UCB Consulting
Jeffrey Callen, MD
  Abbvie Pharmaceuticals, Allergan, Amgen, CVS/Caremark, Celgene Corporation, Genentech, Gilead Sciences, Inc., Glaxo Smith Kline, Johnson and Johnson, Merck & Co, Inc., Novartis, Pfizer, Inc, Procter & Gamble Ownership interest (stock, stock options)
  Elsevier Royalties from Books
  UpToDate, Inc Editor and author

The following faculty has indicated she has no relationship which, in the context of her presentation(s), could be perceived as a potential conflict of interest:

Robert Lafyatis, MD
Emily Littlejohn, DO, MPH
Robert Micheletti, MD



Acknowledgment

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Internet Enduring activity from:

Amgen Inc.
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation


This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education
and the Dermatology and Plastic Surgery Institute.